CRISPR Therapeutics

CRSP

Börsenwert 4,1 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
326	326 Corient IA Miami, Florida	138.532 $	-52.708 $	-1.000	-28 %
327	FP 327 Financial Perspectives Minneapolis, Minnesota	132.096 $	–	–	–
328	328 HM Payson & Co Portland, Maine	126.533 $	-52.708 $	-1.000	-30 %
329	329 Harbor Investment Advisory Lutherville, Maryland	125.442 $	-5.271 $	-100	-4 %
330	330 EFG International Zurich,	120.861 $	+44.222 $	+839	+61 %
331	331 MCF Advisors Covington, Kentucky	119.279 $	–	–	–
332	AWM 332 Aberdeen Wealth Management Lake Bluff, Illinois	115.078 $	+111.214 $	+2.110	Neu
333	333 Cassaday & Co Wealth Management Mclean, Virginia	111.917 $	-10.963 $	-208	-9 %
334	334 Federation des caisses Desjardins du Quebec Levis, Quebec, Canada	110.982 $	-40.690 $	-772	-28 %
335	335 GF Fund Management Guangzhou, China	110.825 $	-5.692 $	-108	-5 %
336	336 Gables Capital Management Miami, Florida	109.080 $	-105.416 $	-2.000	-50 %
337	EP 337 Elkhorn Partners Omaha, Nebraska	109.080 $	+5.271 $	+100	+5 %
338	338 Sterling Capital Management Charlotte, North Carolina	91.300 $	-71.841 $	-1.363	-45 %
339	NEWAS 339 N.E.W. Advisory Services De Pere, Wisconsin	90.918 $	–	–	–
340	BSC 340 BOLTON SECURITIES CORPORATION Bolton, Massachusetts	89.827 $	-17.341 $	-329	-17 %
341	341 Thurston Springer Miller Herd & Titak Indianapolis, Indiana	89.271 $	+55.923 $	+1.061	+184 %
342	AIM 342 Axiom Investment Management New York	82.900 $	+80.116 $	+1.520	Neu
343	343 SignatureFD Atlanta, Georgia	82.083 $	-2.056 $	-39	-3 %
344	344 Larson Financial Group St Louis, Missouri	78.156 $	+5.007 $	+95	+7 %
345	345 Arax Advisory Partners Denver, Colorado	77.230 $	+53.130 $	+1.008	+247 %
346	346 Hantz Financial Services Southfield, Michigan	76.000 $	–	–	–
347	347 National Bank of Canada Montreal, Quebec, Canada	73.913 $	-264 $	-5	-0,4 %
348	348 Evelyn Partners London,	70.902 $	+68.520 $	+1.300	Neu
349	349 BNP Paribas Asset Management Paris, France	69.266 $	-12.861 $	-244	-16 %
350	350 IFP Advisors Tampa, Florida	67.739 $	-17.868 $	-339	-21 %

CRISPR Therapeutics CRSP Börsenwert 4,1 Mrd. $

CRISPR Therapeutics

CRSP

Börsenwert 4,1 Mrd. $